RPS6KB2 and neoplasm: Within the cohort of mice bearing miR-184-overexpressing tumour cells, the expressions of a number of miR-184 targets (e.g., AKT2, GSK3A and S6K2) were reduced in three out of four mice when compared to the control tumours.